Segment And Geographic Information

12 Months Ended

Dec. 31, 2013

Segment And Geographic Information [Abstract]

Segment And Geographic Information

18.  Segment and Geographic Information

The Company has two reportable segments organized according to its products and services: Medical Devices and Preservation Services.  The Medical Devices segment includes external revenues from product sales of BioGlue, BioFoam, PerClot, revascularization technologies, and HeRO Graft.  The Preservation Services segment includes external services revenues from the preservation of cardiac and vascular tissues.  There are no intersegment revenues.

The primary measure of segment performance, as viewed by the Company’s management, is segment gross margin, or net external revenues less cost of products and preservation services.  The Company does not segregate assets by segment; therefore, asset information is excluded from the segment disclosures below. 

The following table summarizes revenues, cost of products and preservation services, and gross margins for the Company’s operating segments (in thousands):

	2013		2012		2011
Revenues:
Medical devices	$	76,194	$	67,496	$	59,387
Preservation services		64,498		63,603		59,793
Othera		71		619		446
Total revenues		140,763		131,718		119,626
Cost of products and preservation services:
Medical devices		15,147		11,380		9,442
Preservation services		35,230		35,320		34,340
Total cost of products and preservation services		50,377		46,700		43,782
Gross margin:
Medical devices		61,047		56,116		49,945
Preservation services		29,268		28,283		25,453
Othera		71		619		446
Total gross margin	$	90,386	$	85,018	$	75,844

Net revenues by product for the years ended December 31, 2013,  2012, and 2011 were as follows (in thousands):

	2013		2012		2011
Products:
BioGlue and BioFoam	$	58,004	$	53,211	$	49,455
PerClot		3,494		3,078		2,528
HemoStase		--		--		1,699
Revascularization technologies		8,965		8,092		5,705
HeRO Graft		5,731		3,115		--
Total products		76,194		67,496		59,387
Preservation services:
Cardiac tissue		29,523		29,756		26,618
Vascular tissue		34,975		33,847		33,175
Total preservation services		64,498		63,603		59,793
Othera		71		619		446
Total revenues	$	140,763	$	131,718	$	119,626

aFor the years ended December 31, 2013,  2012, and 2011 the “Other” designation includes grant revenue.

Net revenues by geographic location attributed to countries based on the location of the customer for the years ended December 31, 2013,  2012, and 2011 were as follows (in thousands):

	2013		2012		2011
U.S.	$	109,325	$	103,804	$	95,975
International		31,438		27,914		23,651
Total revenues	$	140,763	$	131,718	$	119,626

At December 31, 2013 and 2012 over 95% of the long‑lived assets of the Company were held in the U.S., where all of the Company’s manufacturing facilities and the corporate headquarters are located.  At December 31, 2013 and 2012 the Company’s $11.4 million of goodwill was allocated entirely to its Medical Devices segment.